滤泡淋巴瘤（FL）是最常见的惰性B细胞淋巴瘤。2020年美国血液学会（ASH）年会公布了多项关于FL的最新研究进展。包括在一线治疗基础上的进一步方案优化、靶向治疗及嵌合抗原受体T细胞（CAR-T）治疗复发难治FL的临床研究进展。文章将对这些进展进行介绍。“,”Follicular lymphoma (FL) is the most common indolent B-cell lymphoma. The 2020 American Society of Hematology (ASH) Annual Meeting announced the latest updates on FL, including the further optimization based on the frontline treatment, the targeted therapy and the chimeric antigen receptor T cells (CAR-T) in the treatment of relapsed/refractory FL. This article provides an overview of these updates.